Community Search
Come Meet Us: Latest News

Lundbeck announces availability of new therapy for rare neurologic disorder

Tuesday, September 2, 2014   (0 Comments)
Share |


‎WPC Scientific Update Lead Supporter Lundbeck Announces Availability of NORTHERA™ (droxidopa) Capsules in the U.S. for Symptomatic Neurogenic Orthostatic Hypotension (NOH).

NOH is a Disorder Caused by an Underlying Neurologic Disease (e.g., Parkinson's Disease, Multiple System Atrophy or Pure Autonomic Failure)

Read more:

Membership Management Software Powered by YourMembership  ::  Legal